Porton Pharma Solutions Ltd
Porton Pharma Solutions's GHG Emissions Data Preview
In 2024, Porton Pharma Solutions completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Porton Pharma Solutions has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Porton Pharma Solutions’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Porton Pharma Solutions’s data sources below and access millions more through our Disclosure Search.
Insights into Porton Pharma Solutions's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Porton Pharma Solutions amounted to 123,052.46 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Porton Pharma Solutions increased by 12.18%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Porton Pharma Solutions's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Porton Pharma Solutions's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Porton Pharma Solutions were 18,865.22 metric tons of CO₂ equivalent (tCO₂e). a
Has Porton Pharma Solutions reduced its Scope 1 emissions over time?
Since 2022, Porton Pharma Solutions's Scope 1 emissions have decreased by 6.24%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Porton Pharma Solutions's Scope 1 emissions decreased by 5.01%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Porton Pharma Solutions's Scope 2 emissions?
In 2024, Porton Pharma Solutions reported Scope 2 greenhouse gas (GHG) emissions of 104,187.24 tCO₂e without specifying the calculation method. a
Has Porton Pharma Solutions reduced its Scope 2 emissions over time?
Since 2022, Porton Pharma Solutions's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 21.86%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), Porton Pharma Solutions's Scope 2 emissions (Unspecified Calculation Method) rose by 15.98% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Porton Pharma Solutions use for Scope 2 reporting?
In 2024, Porton Pharma Solutions reported its Scope 2 emissions using an unspecified methodology. a
Porton Pharma Solutions's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Porton Pharma Solutions’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Porton Pharma Solutions reported Scope 1 greenhouse gas (GHG) emissions of 18,865.22 tCO₂e and total revenues of USD 413 millions. This translates into an emissions intensity of 45.71 tCO₂e per millions USD. a
Porton Pharma Solutions's Scope 1 Emissions Intensity Compared to Peers
How does Porton Pharma Solutions's GHG emissions intensity compare to its peers?
In 2024, Porton Pharma Solutions reported a Scope 1 emissions intensity of 45.71 tCO₂e per millions USD. Compared to the peer group median of 23.6 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Porton Pharma Solutions rank on GHG emissions intensity within its industry?
In 2024, Porton Pharma Solutions ranked 20 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Porton Pharma Solutions is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a